skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

ファーマインテリジェンスはInforma PLCのインフォーマインテリジェンス部門の一部です

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon レポートストアメルマガ登録製品ログインProductLogin
Global Search Configuration
  • Close Icon

About Sue

USA

+21 year(s) experience

Sue is a senior editor based in Washington, DC, and primarily covers US drug, biologic and biosimilar regulation and policy across therapeutic areas, with an emphasis on advisory committee reviews and FDA approvals. She also covers generic drug and biosimilar patent litigation and other legal issues.
Sue has reported on the prescription and over-the-counter drug industries since 1999 for various publications now under the umbrella of Informa Business Intelligence, including Pink Sheet, "The Pink Sheet" DAILY, "The Tan Sheet" and Scrip. Previously she worked as an editor for Mealey's Litigation Reports (now part of Lexis-Nexis), writing about asbestos, toxic tort and fen-phen litigation. She grew up in South Jersey, where her love for the Philadelphia Phillies and Eagles and home-grown tomatoes was deeply engrained.

Specialties

  • Policy & Regulation
  • Biosimilars
  • Generics

Sue Writes For

Analyst Articles

Articles by Sue